Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2005, p. 4767-4770, Vol. 49, No. 11
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.11.4767-4770.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
TLA-2, a Novel Ambler Class A Expanded-Spectrum ß-Lactamase
Delphine Girlich,1
Laurent Poirel,1
Andreas Schlüter,2 and
Patrice Nordmann1*
Service de Bactériologie-Virologie, Université Paris XI, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France,1
Fakultät für Biologie, Lehrstuhl für Genetik, Universität Bielefeld, D-33615 Bielefeld, Germany2
Received 26 May 2005/
Returned for modification 26 June 2005/
Accepted 24 August 2005

ABSTRACT
ß-Lactamase TLA-2 is encoded by a 47-kb plasmid isolated
from an unidentified bacterial strain from a wastewater treatment
plant. TLA-2 is an Ambler class A ß-lactamase that
shares 52% amino acid identity with CGA-1 from
Chryseobacterium gleum and 51% with TLA-1 from
Escherichia coli. The enzyme hydrolyzes
mostly cephalosporins.

TEXT
Most of the clavulanic acid-inhibited expanded-spectrum Ambler
class A ß-lactamases (ESBL) (
1) are either derivatives
of narrow-spectrum TEM- and SHV-type ß-lactamases
or CTX-M-type ß-lactamases (
3,
11). Plasmid-carried
ESBL genes are found in
Enterobacteriaceae and more rarely in
Pseudomonas aeruginosa (
13). In addition to the so-called classical
ESBL, a series of other Ambler class A (
1) ESBL are known as
BES, GES, PER, SFO, TLA-1, and VEB, with a quite large distribution
of PER- and VEB-type enzymes in
P.aeruginosa (
6,
14,
15,
19,
20,
23).
A survey was previously performed by Szczepanowski et al. (24) to analyze bacterial populations in the activated-sludge compartment of a wastewater treatment plant for the presence of plasmids conferring erythromycin resistance to the host bacterium. Plasmids were extracted and introduced into Escherichia coli strain DH5
by transformation. A 47-kb plasmid (pRSB101) was sequenced, and it was shown to carry a class A ß-lactamase gene, named blaTLA-2 (24).
The purpose of the present study was to analyze the properties of the novel ß-lactamase TLA-2.
The entire blaTLA-2 gene was amplified by PCR with primers TLA-2A (5'-TCCCTGGAGCACTTATGAAT-3') and TLA-2B (5'-ATTAAGGATAAACTCATCCGC-3'), which were designed from the nucleotide sequence under GenBank/EMBL accession no. AJ698325. The gene was cloned into the pPCRBluntII-TOPO plasmid and expressed in E. coli DH10B (Invitrogen, Life Technologies, Cergy-Pontoise, France), giving rise to the E.coli DH10B(pTLA-2) recombinant strain. Antibiotic susceptibility testing by disk diffusion (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France) showed that E. coli DH10B(pTLA-2) displayed a typical clavulanic acid-inhibited ESBL phenotype (data not shown).
MICs of ß-lactams were determined by using the broth microdilution technique according to the Clinical and Laboratory Standards Institute recommendations (9). MICs of ß-lactams showed that this ß-lactamase gene, once expressed from a multicopy plasmid, conferred resistance or reduced susceptibility to cephalosporins, with a major effect on ceftazidime and aztreonam (Table 1). Surprisingly, MICs of amino-, carboxy-, and ureidopenicillins were only slightly modified by the expression of the ß-lactamase TLA-2 (Table 1).
As previously described, the
blaTLA-2 gene was not embedded
in a class 1 integron but it was bracketed by 145-bp direct
repeats of unknown function (
24). The
blaVEB-1 gene has been
identified in
P. aeruginosa 10.2, also bracketed by direct repeats,
but it is not structurally related to
blaTLA-2 (
2).
The TLA-2 ß-lactamase has features of Ambler class A ß-lactamases (1, 24) (Fig. 1). TLA-2 is distantly related to other ß-lactamases and shares the highest amino acid sequence identity with Ambler class A ß-lactamases of gram negatives such as CGA-1 (52%) from Chryseobacterium gleum (4) and with TLA-1 (51%), encoded by plasmid RZA92 from E. coli R170 (23). TLA-2 is weakly related to the other ESBL (Fig. 1). Detailed analysis of the protein sequence of TLA-2 indicated that it might belong to a subgroup of ESBL that, in addition to CGA-1 and TLA-1, also includes CEP-A (21), CFX-A (16), CME-1 (22), PER-1 (15), TLA-1 (23), and VEB-1 (20). TLA-2 shares 39% amino acid identity with PER-1, 33% with CEP-A, and 45% with CME-1 (data not shown).
In order to perform a biochemical analysis of TLA-2, enzyme
purification was carried out by ion-exchange chromatography
as previously described (
17). Briefly, 8 liters of an
E. coli DH10B(pTLA-2) culture in Trypticase soy broth was pelleted,
resuspended, and disrupted by sonication in 60 ml 100 mM sodium
phosphate buffer (pH 7). The protein extracts obtained were
loaded onto a preequilibrated Q-Sepharose column (Amersham Pharmacia
Biotech) with a 20 mM Tris-HCl buffer (pH 8.8). The ß-lactamase
recovered in the flowthrough was subsequently dialyzed against
50 mM sodium phosphate buffer (pH7.2), loaded onto an S-Sepharose
column preequilibrated with the same buffer, and eluted with
a linear NaCl gradient (0to 500 mM). The fractions containing
the highest ß-lactamase activity, as determined by
nitrocefin test (Oxoid, Dardilly, France), were pooled and dialyzed
overnight against 50 mM sodium phosphate buffer (pH 7).
The protein purification rate and the relative molecular mass of the purified ß-lactamase TLA-2 were estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis as previously described (17). Purification of the enzyme was difficult due to low-level biosynthesis. A specific activity of 75 µmol min1 mg of protein1 was determined with 100 µM cephalothin as a substrate, at 30°C in 100 mM sodium phosphate buffer, for the purified ß-lactamase TLA-2. The purification coefficient was calculated to be 35-fold, and its purity was estimated to be >90%. The mature protein had a relative molecular mass of ca. 30 kDa. Isoelectric focusing analysis (5) identified a ß-lactamase with a pI value of 8.8. N-terminal Edman sequencing was performed on an Applied Biosystems Procise 494HT, as previously described (12). N-terminal amino acid sequencing of the mature protein revealed a cleavage site of the deduced blaTLA-2 gene product between residues 22 and 23 (C-K) (Fig. 1).
The purified ß-lactamase TLA-2 was used for kinetic measurements performed at 30°C in 100 mM phosphate buffer as previously described (10, 18). The kcat and Km values were determined by analyzing ß-lactam hydrolysis under initial-rate conditions with a UV spectrophotometer by using the Eadie-Hoffstee linearization of the Michaelis-Menten equation, as previously described (10, 18). The kinetic parameters of the TLA-2 ß-lactamase revealed its activity against restricted and expanded-spectrum cephalosporins (Table 2). The enzyme showed the highest level of activity against cephalothin (kcat value of 90 s1). However, the low affinity (high Km value) reduced the catalytic efficiency (kcat/Km) of TLA-2 against cephalothin. TLA-2 showed an uncommonly high affinity for expanded-spectrum cephalosporins, with Km values greatly lower than those of most ESBL (4-fold lower than that of VEB-1 for cefotaxime and 10-fold lower than that of VEB-1 for ceftazidime) (14, 15, 19, 20, 22, 23). Overall, TLA-2 had a similar hydrolysis profile compared to that of TLA-1, except for aztreonam for which no detectable hydrolysis was observed with TLA-2. TLA-2 had no detectable activity also against amoxicillin, ticarcillin, cefoxitin, and imipenem. For these substrates, determinations of 50% inhibitory concentrations (IC50) or Ki were performed with cephalothin (100 µM) as substrate. TLA-2 was strongly inhibited by ampicillin (Ki value of 1.8 µM), ticarcillin (Ki value of 25 nM), or aztreonam (Ki value of 0.1 µM). Imipenem (IC50 value of 3.5 µM) and cefoxitin (Ki value of 1.7 µM) were also good inhibitors of TLA-2 activity, as observed for GES-1 (19) and PER-1 (15). These high affinities may explain the increased MICs of penicillins and aztreonam observed for E. coli DH10B(pTLA-2) despite lack of significant hydrolysis. Surprisingly, TLA-2 was not inhibited or was weakly inhibited in vitro by ß-lactam inhibitors (Ki value of 300 µM for clavulanic acid and IC50 of >100 µM for tazobactam and 40 µM for sulbactam) although MICs of cephalosporins were significantly lowered by the addition of ß-lactam inhibitors. This characteristic could not be explained by any known mutation present in inhibitor-resistant TEM (IRT) ß-lactamases (8). Residues 69 (Met) and 276 (Asn) of TEM-1 ß-lactamase are conserved in TLA-2, whereas they are not in IRT enzymes, while other residues conferring resistance in IRT enzymes (8), found in TLA-2 ß-lactamase, were also found in other ESBL of the PER-1 subgroup, which remain susceptible to ß-lactam inhibitors. The apparent discrepancy between in vitro and in vivo susceptibilities remains to be explained.
According to its functional properties, TLA-2 could be included
in group 2e of the Bush-Jacoby-Medeiros classification scheme
(
7), since it exhibits good catalytic efficiencies toward most
cephalosporins and not toward penicillins, but it lacks sensitivity
to ß-lactam inhibitors, which does not fit the criteria
of this class of ß-lactamases. This report extends
the variety of Ambler class A ESBL (
1) that may be identified
in a waterborne environment. Although there is not any evidence
yet for diffusion of TLA-2 in the clinical setting, the fact
that this enzyme can degrade expanded-spectrum cephalosporins
and is encoded by a mobilizable plasmid might anticipate future
clinical relevance.

ACKNOWLEDGMENTS
This work was funded by a grant from the Ministère de
l'Education Nationale et de la Recherche (UPRES-EA 3539), Université
Paris XI, Paris, France, and the European Community (6th PCRD,
LSHM-CT-2003-503-335). L.P. is a researcher from the INSERM
(Paris, France).

FOOTNOTES
* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cédex, France. Phone: 33-1-45-21-36-32. Fax: 33-1-45-21-63-40. E-mail:
nordmann.patrice{at}bct.ap-hop-paris.fr.


REFERENCES
1 - Ambler, R. P., A. F. W. Coulson, J.-M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Lévesque, G. Tiraby, and S. G. Wakey. 1991. A standard numbering scheme for class A ß-lactamases. Biochem. J. 276:269-272.
2 - Aubert, D., D. Girlich, T. Naas, S. Nagarajan, and P. Nordmann. 2004. Functional and structural characterization of the genetic environment of an extended-spectrum ß-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob. Agents Chemother. 48:3284-3290.[Abstract/Free Full Text]
3 - Bauernfeind, A., I. Stemplinger, R. Jungwirth, S. Ernst, and J. M. Casellas. 1996. Sequences of ß-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other ß-lactamases. Antimicrob. Agents Chemother. 40:509-513.[Abstract]
4 - Bellais, S., T. Naas, and P. Nordmann. 2002. Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum. Antimicrob. Agents Chemother. 46:966-970.[Abstract/Free Full Text]
5 - Bellais, S., L. Poirel, T. Naas, D. Girlich, and P. Nordmann. 2000. Genetic-biochemical analysis and distribution of the Ambler class A ß-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob. Agents Chemother. 44:1-9.[Abstract/Free Full Text]
6 - Bonnet, R., J. L. Sampaio, C. Chanal, D. Sirot, C. De Champs, J. L. Viallard, R. Labia, and J. Sirot. 2000. A novel class A extended-spectrum ß-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob. Agents Chemother. 44:3061-3068.[Abstract/Free Full Text]
7 - Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for ß-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.[Medline]
8 - Chaibi, E. B., D. Sirot, G. Paul, and R. Labia. 1999. Inhibitor-resistant TEM ß-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43:447-458.[Abstract/Free Full Text]
9 - Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing, 15th informational supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa.
10 - Cornish-Bowden, A. (ed.). 1995. Graphs of the Michaelis-Menten equation, p. 30-37. In Fundamentals of enzyme kinetics. Portland Press, Inc., Seattle, Wash.
11 - Eckert, C., V. Gautier, M. Saladin-Allard, N. Hidri, C. Verdet, Z. Ould-Hocine, G. Barnaud, F. Delisle, A. Rossier, T. Lambert, A. Philippon, and G. Arlet. 2004. Dissemination of CTX-M-type ß-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48:1249-1255.[Abstract/Free Full Text]
12 - Girlich, D., T. Naas, and P. Nordmann. 2004. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:2043-2048.[Abstract/Free Full Text]
13 - Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum ß-lactamases. Antimicrob. Agents Chemother. 35:1697-1704.[Free Full Text]
14 - Matsumoto, Y., and M. Inoue. 1999. Characterization of SFO-1, a plasmid-mediated inducible class A ß-lactamase from Enterobacter cloacae. Antimicrob. Agents Chemother. 43:307-313.[Abstract/Free Full Text]
15 - Nordmann, P., E. Ronco, T. Naas, C. Duport, Y. Michel-Briand, and R. Labia. 1993. Characterization of a novel extended-spectrum ß-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:962-969.[Abstract/Free Full Text]
16 - Parker, A. C., and C. J. Smith. 1993. Genetic and biochemical analysis of a novel Ambler class A ß-lactamase responsible for cefoxitin resistance in Bacteroides species. Antimicrob. Agents Chemother. 37:1028-1036.[Abstract/Free Full Text]
17 - Philippon, L. N., T. Naas, A.-T. Bouthors, V. Barakett, and P. Nordmann. 1997. OXA-18, a class D clavulanic acid-inhibited extended-spectrum ß-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2195-2198.
18 - Poirel, L., D. Girlich, T. Naas, and P. Nordmann. 2001. OXA-28, an extended-spectrum variant of OXA-10 ß-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene. Antimicrob. Agents Chemother. 45:447-453.[Abstract/Free Full Text]
19 - Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum ß-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.[Abstract/Free Full Text]
20 - Poirel, L., T. Naas, M. Guibert, E. B. Chaibi, R. Labia, and P. Nordmann. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum ß-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43:573-581.[Abstract/Free Full Text]
21 - Rogers, M. B., A. C. Parker, and C. J. Smith. 1993. Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A ß-lactamases. Antimicrob. Agents Chemother. 37:2391-2400.[Abstract/Free Full Text]
22 - Rossolini, G. M., N. Franceschini, L. Lauretti, B. Caravelli, M. L. Riccio, M. Galleni, J.-M. Frère, and G. Amicosante. 1999. Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaCME) encoding an extended-spectrum class A ß-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER ß-lactamases. Antimicrob. Agents Chemother. 43:2193-2199.[Abstract/Free Full Text]
23 - Silva, J., C. Aguilar, G. Ayala, M. A. Estrada, U. Garza-Ramos, R. Lara-Lemus, and L. Ledezma. 2000. TLA-1: a new plasmid-mediated extended-spectrum ß-lactamase from Escherichia coli. Antimicrob. Agents Chemother. 44:997-1003.[Abstract/Free Full Text]
24 - Szczepanowski, R., I. Krahn, B. Linke, A. Goesmann, A. Pühler, and A. Schlüter. 2004. Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system. Microbiology 150:3613-3630.[Abstract/Free Full Text]
25 - Tranier, S., A. T. Bouthors, L. Maveyraud, V. Guillet, W. Sougakoff, and J. P. Samama. 2000. The high resolution crystal structure for class A ß-lactamase PER-1 reveals the bases for its increase in breadth of activity. J. Biol. Chem. 275:28075-28082.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, November 2005, p. 4767-4770, Vol. 49, No. 11
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.11.4767-4770.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Reglier-Poupet, H., Naas, T., Carrer, A., Cady, A., Adam, J.-M., Fortineau, N., Poyart, C., Nordmann, P.
(2008). Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum {beta}-lactamases. J Med Microbiol
57: 310-315
[Abstract]
[Full Text]
-
Naas, T., Aubert, D., Lambert, T., Nordmann, P.
(2006). Complex Genetic Structures with Repeated Elements, a sul-Type Class 1 Integron, and the blaVEB Extended-Spectrum {beta}-Lactamase Gene.. Antimicrob. Agents Chemother.
50: 1745-1752
[Abstract]
[Full Text]